Pharma sector stocks in India
The pharma sector at a glance: how its index is performing, how many of its 116 tracked stocks are in uptrends, how it is valued, and which companies lead and lag.
Data as of 21 Sep 2026 close
Index trend: Uptrend
The Nifty Pharma index has returned +2.3% over one month, +10.5% over three months and +20.9% over a year, and is currently in a uptrend.
Of the 116 pharma stocks we track, 73% trade above their 200-day moving average and 65% above their 50-day average; 11 made a new 52-week high in the latest session.
The median P/E of profitable pharma companies with market cap above ₹500 Cr is 38.5, with a median ROE of 12.6%.
Nifty Pharma index performance
Index close
27,021.15
+1.16% today
Return 1 month
+2.29%
Return 3 months
+10.47%
Return 6 months
+19.84%
Return 1 year
+20.95%
Breadth: how many pharma stocks are trending up
Stocks tracked
116
Above 20-DMA
58.6%
Above 50-DMA
64.7%
Above 200-DMA
72.7%
Average RSI
55.2
Median 3M return
+10.2%
52-week highs / lows
11 / 0
Breakouts / breakdowns
15 / 3
Technical breakdown of the pharma sector →
Best 1-month performers
| Stock | 1M | Score |
|---|---|---|
| AHCLAnlon Healthcare Limited | +82.6% | 78 |
| KOPRANKopran Limited | +41.7% | 84 |
| VALIANTLABValiant Laboratories Limited | +38.6% | 76 |
| NOVARTINDNovartis India | +35.2% | 56 |
| SAKARSakar Healthcare Limited | +31.0% | 77 |
| SMSPHARMASMS Pharmaceuticals Limited | +30.9% | 78 |
| MEDICAMEQMedicamen Biotech Limited | +30.5% | 72 |
| SHILPAMEDShilpa Medicare Limited | +30.4% | 84 |
Weakest 1-month performers
| Stock | 1M | Score |
|---|---|---|
| MEDICOMedico Remedies Limited | -19.0% | 6 |
| PFIZERPfizer Limited | -18.0% | 14 |
| WANBURYWanbury Limited | -15.2% | 18 |
| ASTRAZENAstraZeneca Pharma India Limited | -11.4% | 22 |
| NGLFINENGL Fine-Chem Limited | -9.9% | 44 |
| VENUSREMVenus Remedies Limited | -9.8% | 30 |
| BETABeta Drugs Limited | -9.6% | 32 |
| HESTERBIOHester Biosciences Limited | -9.3% | 47 |
Largest pharma companies by market cap
Across 102 pharma companies above ₹500 Cr: median P/E 38.5, median ROE 12.6%, median 3-year sales growth 11%.
| # | Company | Market cap | P/E | ROE | Debt/Eq | Sales CAGR 3Y | Return 6M |
|---|---|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries LimitedSUNPHARMA · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹448,412 Cr | 37.05 | 14.5% | 0.06 | +10.0% | +4.1% |
| 2 | Divi's Laboratories LimitedDIVISLAB · Pharmaceuticals - Indian - Bulk Drugs | ₹249,819 Cr | 85.41 | 17.5% | 0.00 | +11.0% | +56.5% |
| 3 | Torrent Pharmaceuticals LimitedTORNTPHARM · Pharmaceuticals - Indian - Formulations | ₹189,043 Cr | 87.68 | 25.7% | 1.79 | +13.0% | +15.6% |
| 4 | Zydus Lifesciences LimitedZYDUSLIFE · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹115,810 Cr | 27.18 | 15.7% | 0.46 | +16.0% | +28.5% |
| 5 | Cipla LimitedCIPLA · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹111,977 Cr | 33.36 | 9.7% | 0.02 | +7.0% | +11.4% |
| 6 | Laurus Labs LimitedLAURUSLABS · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹109,008 Cr | 99.97 | 20.6% | 0.48 | +4.0% | +97.1% |
| 7 | Mankind Pharma LimitedMANKIND · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹100,692 Cr | 48.71 | 12.7% | 0.39 | +18.0% | +20.4% |
| 8 | Dr. Reddy's Laboratories LimitedDRREDDY · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹99,817 Cr | 30.50 | 8.6% | 0.20 | +11.0% | -7.9% |
| 9 | Aurobindo Pharma LimitedAUROPHARMA · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹98,585 Cr | 26.57 | 9.8% | 0.21 | +11.0% | +31.0% |
| 10 | Lupin LimitedLUPIN · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹97,146 Cr | 18.14 | 23.9% | 0.29 | +19.0% | -9.5% |
| 11 | Glenmark Pharmaceuticals LimitedGLENMARK · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹69,145 Cr | 38.47 | 17.1% | 0.06 | +14.0% | +13.0% |
| 12 | Biocon LimitedBIOCON · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹64,318 Cr | 154.31 | 1.2% | 0.45 | +15.0% | +4.0% |
| 13 | Alkem Laboratories LimitedALKEM · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹64,135 Cr | 29.32 | 15.8% | 0.15 | +8.0% | -1.3% |
| 14 | Abbott India LimitedABBOTINDIA · Pharmaceuticals - Multinational | ₹57,288 Cr | 39.64 | 30.3% | 0.04 | — | +2.1% |
| 15 | IPCA Laboratories LimitedIPCALAB · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹50,949 Cr | 36.95 | 17.1% | 0.10 | +16.0% | +27.9% |
| 16 | Gland Pharma LimitedGLAND · Pharmaceuticals - Indian - Formulations | ₹48,503 Cr | 47.20 | 9.9% | 0.03 | +21.0% | +71.9% |
| 17 | GlaxoSmithKline Pharmaceuticals LimitedGLAXO · Pharmaceuticals - Multinational | ₹48,499 Cr | 45.42 | 47.1% | 0.01 | +6.0% | +23.3% |
| 18 | Ajanta Pharma LimitedAJANTPHARM · Pharmaceuticals - Indian - Formulations | ₹44,262 Cr | 38.99 | 25.1% | 0.06 | +13.0% | +23.0% |
| 19 | Emcure Pharmaceuticals LimitedEMCURE · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹38,119 Cr | 37.41 | 20.6% | 0.31 | +15.0% | +26.1% |
| 20 | Wockhardt LimitedWOCKPHARMA · Pharmaceuticals - Indian - Bulk Drugs & Formln | ₹35,542 Cr | 100.69 | 7.1% | 0.45 | +8.0% | +82.7% |
Compare pharma leaders
Sun Pharmaceutical vs Zydus LifesciencesSun Pharmaceutical vs CiplaDivi's Laboratories vs Neuland LaboratoriesDivi's Laboratories vs Jubilant PharmovaTorrent Pharmaceuticals vs Gland PharmaTorrent Pharmaceuticals vs Ajanta PharmaZydus Lifesciences vs CiplaAbbott India vs GlaxoSmithKline PharmaceuticalsGland Pharma vs Ajanta PharmaAbbott India vs PfizerGlaxoSmithKline Pharmaceuticals vs PfizerRubicon Research vs Acutaas Chemicals
Industries in this sector
Pharmaceuticals (83)Pharmaceuticals - Indian - Bulk Drugs & Formln (67)Pharmaceuticals - Indian - Formulations (26)Pharmaceuticals - Indian - Bulk Drugs (14)Pharmaceuticals - Multinational (7)
